Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing-Reference-Cited by-同舟云学术

Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing

Published:2012-10-17 Issue:4 Volume:2 Page:158-174
ISSN:2075-4426
Container-title:Journal of Personalized Medicine
language:en
Short-container-title:JPM

Author:

Canestaro William J.,Brooks David G.,Chaplin Donald,Choudhry Niteesh K.,Lawler Elizabeth,Martell Lori,Brennan Troyen,Wassman E. Robert

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Link

http://www.mdpi.com/2075-4426/2/4/158/pdf

Reference73 articles.

1. NHLBI Fact Bookhttp://www.nhlbi.nih.gov/about/factpdf.htm

2. Heart Disease and Stroke Statistics—2012 Update

3. The use of medicines in the united states: Review of 2011http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf

4. Cerivastatin and reports of fatal rhabdomyolysis;Staffa;N. Engl. J. Med.,2002

5. Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between genetic polymorphisms in apolipoprotein E and atrial fibrillation;Revista Portuguesa de Cardiologia;2022-05

2. Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study;European Journal of Clinical Pharmacology;2021-10-19

3. Optimization of statin use: genetic factors and therapeutic drug monitoring;Pharmacogenetics and Pharmacogenomics;2020-12-28

4. A Glimpse into Pharmacogenomics in Africa;The Genetics of African Populations in Health and Disease;2019-12-19

5. THE ROLE OF GENE POLYMORPHISMS IN INDIVIDUALLY CHANGING OF THE LIPID PROFILE AMONG PATIENTS WITH CORONARY ARTERY DISEASE UNDER THE INFLUENCE OF THE STATIN THERAPY;Modern medical technologies;2019-10